Description: Marquis® Oral Paste for horses is indicated for the treatment of equine protozoal myeloencephalitis (EPM) caused by Sarcocystis neurona. EPM is one of the most common equine central nervous system disorders in horses. The sooner EPM is diagnosed and appropriately treated, the better the chance of recovery.
Product: Marquis® Oral Paste
For: Horses
Generic Name: Ponazuril
Brand Names: Marquis® Oral Paste
Drug Class: Antiprotozoal
Manufacturer: Boehringer Ingelheim
Benefits:
Comes in a ready–to–use, easy–click syringe containing 127 grams of paste making administration simpleEach gram of paste contains 150 mg of ponazuril an anticoccidial (antiprotozoal) compound useful against several genera of the phylumApicomplexaApicomplexaFirst FDA–approved treatment for EPM in horsesActive ingredient ponazuril crosses the blood brain barrierEasy once–a–day administration for 28 daysSafe to use in mammals because it only targets the merozoite stages of the protozoaPre–calibrated oral dosing syringe ensures easy and accurate dose deliveryOral paste has a gel–like consistency that coats the horseâs mouth, making it difficult to spit it out1 ct carton contains 1 (127 gram) syringe applicator and 1 syringe plunger4 ct carton contains 4 (127 gram) syringe applicators and 4 syringe plungersEach syringe applicator contains enough paste to treat one (1200 lb) horse for 7 days or to treat one (1200 lb) horse with a single loading dose and for 4 daysEach syringe plunger contains a dosage ring calibrated for a dose rate of 5 mg⁄kg body weight and marked for horse weight from 600 to 1200 lbs 
